These two lncRNAs, HOTAIR and H19, have been demonstrated to be overexpressed in breast cancer; this has been related with predictive value to assess resistance to neoadjuvant chemotherapy in breast cancer [8,9]. This evidence concerns the gene H19 and breast carcinoma.